Pharma companies have to deal with a lot of hurdles to allow people to collaborate with them online which may explain why they are such late adopters Regulations restrict social media use by biotechs, pharma – Mass High Tech Business News. Related articles Biotech, pharma warming up to Facebook (fiercebiotechit.com) Is FDA keeping social media…
E-mails suggest Pfizer tried to suppress study on drug – The Boston Globe. Here we go again. Not just Vioxx and the ghost writing scare but now also Neurontin. Emails can get your company in a lot of trouble Related articles Pfizer’s Arthritis Treatment Wins Approval From US FDA – Bloomberg (bloomberg.com) Pfizer’s Xeljanz story reveals why new drug development…
Vertex: Planning Trial Supplies Using Tourtellotte Software – Bio-IT World. Related articles A Non-Earnings Boost for Vertex (fool.com) Why You Should Be Bullish On Vertex Now (seekingalpha.com) Vertex surges as rival hep C contender plays catch-up in clinic (fiercebiotech.com) Bristol-Myers’ Hepatitis Stumble Boosts Gilead, Vertex (minyanville.com) Vertex Wins EU Approval for Cystic Fibrosis Drug…